← Back to Clinical Trials
Recruiting NCT06232512

NCT06232512 Multimodal Haptic Feedback for Plantar Sensory Substitution

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06232512
Status Recruiting
Phase
Sponsor Shirley Ryan AbilityLab
Condition Hypoesthesia
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2023-04-20
Primary Completion 2026-07-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 85 Years
Study Type INTERVENTIONAL
Interventions
Haptic Device

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2023-04-20 with a primary completion date of 2026-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study will explore the use of a haptic device for sensory substitution in individuals with a movement disorder that has caused loss of plantar sensation. The haptic device consists of two components. The first element is a flexible insole with embedded pressure-sensing elements that transmit the spatial patterns of applied foot pressure over time. The second element is a haptic receiver with embedded actuators that vibrate or heat up in proportion to the transmitted pressure patterns, thus substituting the patient's lost plantar sensation.

Eligibility Criteria

Inclusion Criteria: * Able to ambulate 10 meters with or without assistance * Able and willing to give written consent and comply with study procedures Exclusion Criteria: * Unable to give written consent or comply with study procedures * Unable to perceive unsafe levels of heat in relevant areas * Has a motor complete spinal cord injury * Have transfemoral (above knee) amputation * Any condition that would prevent the safe completion of study activities, as determined by the Principal Investigator

Contact & Investigator

Central Contact

Shreya Aalla, BS

✉ saalla@sralab.org

📞 312-238-7323

Principal Investigator

Arun Jayaraman, PT, PhD

PRINCIPAL INVESTIGATOR

Shirley Ryan AbilityLab

Frequently Asked Questions

Who can join the NCT06232512 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Hypoesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06232512 currently recruiting?

Yes, NCT06232512 is actively recruiting participants. Contact the research team at saalla@sralab.org for enrollment information.

Where is the NCT06232512 trial being conducted?

This trial is being conducted at Chicago, United States.

Who is sponsoring the NCT06232512 clinical trial?

NCT06232512 is sponsored by Shirley Ryan AbilityLab. The principal investigator is Arun Jayaraman, PT, PhD at Shirley Ryan AbilityLab. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology